Intra-Cellular Therapies Inc (ITCI) receives an Outperform rating from Robert W. Baird
In a filing, Intra-Cellular Therapies Inc revealed its Chairman, President & CEO Mates Sharon unloaded Company’s shares for reported $1.34 million on Mar 11 ’24. In the deal valued at $65.21 per share,20,565 shares were sold. As a result of this transaction, Mates Sharon now holds 1,050,309 shares worth roughly $72.49 million. Then, Hineline Lawrence […]
Intra-Cellular Therapies Inc [ITCI] Insider Selling: Time to sell?
Intra-Cellular Therapies Inc’s filing revealed that its Chairman, President & CEO Mates Sharon unloaded Company’s shares for reported $1.34 million on Mar 11 ’24. In the deal valued at $65.21 per share,20,565 shares were sold. As a result of this transaction, Mates Sharon now holds 1,050,309 shares worth roughly $68.74 million. Then, Hineline Lawrence J. […]
Intra-Cellular Therapies Inc [NASDAQ: ITCI] Sees Decrease in Stock Value
Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Intra-Cellular Therapies Inc shares valued at $1,341,123 were sold by Mates Sharon on Mar 11 ’24. At $65.21 per share, Mates Sharon sold 20,565 shares. The insider’s holdings dropped to 1,050,309 shares worth approximately $67.82 million following […]
An Analysis of Intra-Cellular Therapies Inc (ITCI)’s Potential Price Growth
Intra-Cellular Therapies Inc’s filing revealed that its Chairman, President & CEO Mates Sharon unloaded Company’s shares for reported $1.34 million on Mar 11 ’24. In the deal valued at $65.21 per share,20,565 shares were sold. As a result of this transaction, Mates Sharon now holds 1,050,309 shares worth roughly $68.72 million. Then, Hineline Lawrence J. […]
Negative sentiment towards ITCI reflected in surge in short interest
The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. Intra-Cellular Therapies Inc shares valued at $1,458,650 were sold by VAN NOSTRAND ROBERT L on Feb 27 ’24. At $72.93 per share, VAN NOSTRAND ROBERT L sold 20,000 shares. The insider’s […]
Intra-Cellular Therapies Inc [ITCI] Insider Activity: An Update for Investors
Intra-Cellular Therapies Inc’s recently made public that its Director VAN NOSTRAND ROBERT L unloaded Company’s shares for reported $1.46 million on Feb 27. In the deal valued at $72.93 per share,20,000 shares were sold. As a result of this transaction, VAN NOSTRAND ROBERT L now holds 9,611 shares worth roughly $0.65 million. Then, MARCUS JOEL […]
Days-to-cover ratio for ITCI surges to 4.51 due to rise in short interest
Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Intra-Cellular Therapies Inc shares valued at $1,458,650 were sold by VAN NOSTRAND ROBERT L on Feb 27. At $72.93 per share, VAN NOSTRAND ROBERT L sold 20,000 shares. The insider’s holdings dropped to 9,611 shares worth approximately […]
Intra-Cellular Therapies Inc [ITCI] Investment Appeal on the Rise
Intra-Cellular Therapies Inc’s filing revealed that its Chairman, President & CEO Mates Sharon unloaded Company’s shares for reported $2.27 million on Feb 02. In the deal valued at $67.07 per share,33,885 shares were sold. As a result of this transaction, Mates Sharon now holds 1,050,309 shares worth roughly $75.16 million. Then, Neumann Mark sold 11,860 […]
ITCI Shares Experience Decline in Value
Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. Intra-Cellular Therapies Inc shares valued at $2,272,694 were sold by Mates Sharon on Feb 02. At $67.07 per share, Mates Sharon sold 33,885 shares. The insider’s holdings dropped to 1,050,309 shares worth approximately $75.55 […]
Intra-Cellular Therapies Inc [ITCI] Insider Mates Sharon sells 33,885 Shares – Insider Selling Alert
Intra-Cellular Therapies Inc’s recently made public that its Chairman, President & CEO Mates Sharon unloaded Company’s shares for reported $2.27 million on Feb 02. In the deal valued at $67.07 per share,33,885 shares were sold. As a result of this transaction, Mates Sharon now holds 1,050,309 shares worth roughly $79.46 million. Then, Neumann Mark sold […]